Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Adjustments to IP framework needed to improve access to medicines in Europe

16 November 2021

Access to generic and biosimilar medicines can be improved with coherent proposals for IP […]

Read more

Access to medicines critical in European Parliament vote on EU IP action plan

12 November 2021

The European Parliament Own Initiative Report on an intellectual property […]

Read more

European Commission pilot project on repurposing brings value added innovation to life

28 October 2021

Innovation on existing, well-known molecules through repurposing can deliver huge benefits for patients and address unmet medical needs sustainably. Today […]

Read more

Smart use of off-patent medicines will be critical to rebuild healthcare systems successfully post-Covid

7 October 2021

Open

Baton passes from Christoph Stoller to Rebecca Guntern as President of Medicines for Europe

1 October 2021

Rebecca Guntern (Sandoz) today begins an interim term as President […]

Read more

HERA must address outstanding weaknesses in EU pharma framework to be successful

16 September 2021

Medicines For Europe strongly supports the EU’s drive to learn from COVID-19 […]

Read more

EU must take the lead to ensure security of supply for medicines

16 June 2021

Legislative reforms aligned with current off-patent market conditions are the […]

Read more

Open borders that prioritise essential goods key to medicines supply in Europe

2 June 2021

Open

EU Industrial strategy should be key to improving medicines supply chains

17 May 2021

The newly launched update of the industrial strategy aims to […]

Read more

“Off patent medicines essential for a fairer, healthier, and sustainable Europe” says President Christoph Stoller

30 April 2021

Christoph Stoller will speak at 3A CONFERENCE – Availability, Accessibility, […]

Read more

Subscribe to our newsletter